Azilect Tablets (Rasagiline Mesylate)

Adult dose

This drug is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If it is well tolerated and the clinical response is insufficient, the dose may be increased to 1mg once daily. This drug may be taken with or without food.

This medication should not be administered to patients with allergies to specific components. It should also not be used in patients who are taking other monoamine oxidase inhibitors or have stopped taking them within the last 2 weeks. Patients currently taking medications such as petidine, tramadol, or dextromethorphan should be cautious, as taking this medication together can be dangerous. It is not safe to use this medication in patients with moderate or severe liver dysfunction. Clinical trials and post-marketing studies have reported various side effects, including headaches, dizziness, depression, hallucinations, rashes, gastrointestinal disorders, and myalgia. There may also be neurological and psychiatric side effects such as movement disorders, hypotension, and impulse control disorders, requiring regular monitoring. This medication can interact with other drugs, so caution is needed when used with antidepressants, sympathomimetics, and CYP1A2 inhibitors. Women who are pregnant or breastfeeding should use this medication with caution, and its safety and efficacy have not been established in children under 18. Additionally, this medication may cause drowsiness or sudden sleep, so caution is advised when driving or operating machinery. In case of overdose, serious side effects may occur; immediate consultation with healthcare professionals is required, and as there is no specific antidote, appropriate treatment according to symptoms is necessary. Store this medication out of reach of children and protect it from direct sunlight, keeping it at temperatures between 1-25 degrees Celsius.

Influenza

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and the appropriate storage temperature is a cool place between 1 and 25 degrees Celsius. This storage method will help maintain the medication's effectiveness for a longer period.

Appearance

White or nearly white, flat, round tablets with a bevelled edge, engraved with 'GIL' on the upper side and '1' on the lower side.

Package unit

30 tablets (10 tablets/PTP × 3), 30 tablets/bottle